BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22181351)

  • 21. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
    Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
    Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
    Glowinska B; Urban M; Peczynska J; Florys B
    Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial.
    Tahir M; Foley B; Pate G; Crean P; Moore D; McCarroll N; Walsh M
    Am Heart J; 2005 Aug; 150(2):302-6. PubMed ID: 16086935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers?
    Van Hoydonck PG; Schouten EG; Manuel-Y-Keenoy B; van Campenhout A; Hoppenbrouwers KP; Temme EH
    Eur J Clin Nutr; 2004 Dec; 58(12):1587-93. PubMed ID: 15127090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively.
    Musiał K; Zwolińska D; Berny U; Polak-Jonkisz D; Szprynger K; Szczepańska M
    Rocz Akad Med Bialymst; 2004; 49():209-12. PubMed ID: 15631345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.
    Rosenson RS; Wolff D; Tangney CC
    Clin Sci (Lond); 2004 Feb; 106(2):215-7. PubMed ID: 12967321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients.
    Lobo JC; Mafra D; Farage NE; Faulin Tdo E; Abdalla DS; de Nóbrega AC; Torres JP
    Clin Chim Acta; 2011 Sep; 412(19-20):1788-92. PubMed ID: 21676364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.
    Zeitler H; Ko Y; Zimmermann C; Nickenig G; Glänzer K; Walger P; Sachinidis A; Vetter H
    Eur J Med Res; 1997 Sep; 2(9):389-94. PubMed ID: 9300936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble adhesion molecules in acute ischemic stroke.
    Simundic AM; Basic V; Topic E; Demarin V; Vrkic N; Kunovic B; Stefanovic M; Begonja A
    Clin Invest Med; 2004 Apr; 27(2):86-92. PubMed ID: 15202827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
    Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
    J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6, but not soluble adhesion molecules, predicts a subsequent mortality from cardiovascular disease in patients with acute ST-segment elevation myocardial infarction.
    Fan ZX; Hua Q; Li YP; Liu RK; Yang Z
    Cell Biochem Biophys; 2011 Nov; 61(2):443-8. PubMed ID: 21594636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Why and how correct calcidiol deficiency in haemodialysis patients?].
    Maheut H; Chevriot F; Marty H; Lavaud S; Kazes I; Chanard J; Rieu P
    Nephrol Ther; 2009 Nov; 5(6):542-9. PubMed ID: 19553166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.